Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Case not yet closed on extra quality marks in Germany?

This article was originally published in Clinica

Executive Summary

The fate of additional quality marks in Germany over and above the CE marking may not be the foregone conclusion that it seemed only last month. The medical devices industry, in Germany in particular, has been urging that the CE marking be the single and only standard available, in order to avoid confusion in the market. Indeed, that is what is laid out in the proposed second amendment of the MPG, Germany's medical products law, which comes into effect next year (Clinica No 918, p 4).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076952

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel